This activity is intended to meet the needs of physicians, physician assistants, nurse practitioners, and nurses.
Upon completion of the educational activity, participants should be able to:
- Discuss the diagnosis, presentation and impact on patient’s with various facial and scar concerns
- Discuss combination therapy with platelet rich plasma (PRP) and chemical peels
- Review the science & clinical literature regarding the use of microneedling (MN) in multiple aesthetics conditions
Method of Participation
In order to receive credit, participants should watch the entire video. Statements of credit will be awarded upon completion of the post test and online evaluation/claim credit form. If you have questions about this CME/CE activity, please contact AKH Inc. at firstname.lastname@example.org.
CME/CE Credit Provided by AKH Inc., Advancing Knowledge in Healthcare. This activity is jointly-provided by AKH Inc., Advancing Knowledge in Healthcare and REVIVE™.
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and REVIVE™. AKH Inc., Advancing Knowledge in Healthcare is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for Physicians.
AKH Inc., Advancing Knowledge in Healthcare designates this enduring activity for a maximum of 3.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME.
AKH Inc., Advancing Knowledge in Healthcare is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
This activity is awarded 3.0 contact hours.
This activity has been planned and implemented in accordance with the accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and and REVIVE™.
AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider Number: 030803.
This activity is approved for 3.0 contact hours which includes 3.0 hours of pharmacology. Activity ID # 22115.
This activity was planned in accordance with AANP Accreditation Standards and Policies.
|Amelia Hausauer, MD||N/A||Nothing to Disclose|
|Dorothy Caputo, MA, BSN, RN – Director of Accreditations||N/A||Nothing to Disclose|
|Bernadette Marie Makar, MSN, NP-C, APRN-C – Nurse Planner||N/A||Nothing to Disclose|
|AKH Inc. Staff and Planners||N/A||Nothing to Disclose|
|REVIVE™ Staff and Planners||N/A||Nothing to Disclose|
This activity is NOT supported by an educational grant.
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are resolved by AKH prior to accreditation of the activity and may include any of or combination of the following: attestation to non-commercial content; notification of independent and certified CME/CE expectations; referral to National Author Initiative training; restriction of topic area or content; restriction to discussion of science only; amendment of content to eliminate discussion of device or technique; use of other author for discussion of recommendations; independent review against criteria ensuring evidence support recommendation; moderator review; and peer review.
Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant’s misunderstanding of the content.